Journal article Open access Published 2024
New Inhibitors of Bcr-Abl Based on 2,6,9-Trisubstituted Purine Scaffold Elicit Cytotoxicity in Chronic Myeloid Leukemia-Derived Cell Lines Sensitive and Resistant to TKIs
Pharmaceutics 16(5), 649 (2024)
- 2024 Year
- 38794311 PMID
Cite this publication
DELGADO, T., V. D., H. DOSTÁLOVÁ, V. KRYŠTOF, V. VOJÁČKOVÁ, R. JORDA, A. CASTRO, J. BERTRAND, G. RIVERA, M. FAUNDEZ, M. STRNAD, C. ESPINOSA-BUSTOS, O. SALAS C.: New Inhibitors of Bcr-Abl Based on 2,6,9-Trisubstituted Purine Scaffold Elicit Cytotoxicity in Chronic Myeloid Leukemia-Derived Cell Lines Sensitive and Resistant to TKIs. Pharmaceutics. 2024, 16(5), 649, ISSN: 1999-4923, PMID: 38794311, PDF.
Details
- ISSN
- 1999-4923